Hsbc Holdings PLC Buys 19,788 Shares of Envista Holdings Corporation $NVST

Hsbc Holdings PLC grew its stake in Envista Holdings Corporation (NYSE:NVSTFree Report) by 31.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 83,350 shares of the company’s stock after buying an additional 19,788 shares during the period. Hsbc Holdings PLC’s holdings in Envista were worth $1,821,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP lifted its position in shares of Envista by 0.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 9,628,460 shares of the company’s stock valued at $209,036,000 after buying an additional 90,586 shares in the last quarter. Alliancebernstein L.P. increased its holdings in Envista by 34.0% in the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after acquiring an additional 1,547,656 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Envista by 15.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock worth $72,726,000 after acquiring an additional 444,725 shares during the period. Millennium Management LLC lifted its holdings in Envista by 1,442.7% during the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock valued at $52,552,000 after purchasing an additional 2,263,712 shares in the last quarter. Finally, AQR Capital Management LLC lifted its holdings in Envista by 72.3% during the fourth quarter. AQR Capital Management LLC now owns 2,356,968 shares of the company’s stock valued at $51,170,000 after purchasing an additional 988,714 shares in the last quarter.

Envista Price Performance

Shares of Envista stock traded up $0.19 on Friday, hitting $25.95. 3,757,959 shares of the company traded hands, compared to its average volume of 2,444,100. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The business has a 50-day simple moving average of $24.84 and a 200 day simple moving average of $25.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The stock has a market capitalization of $4.22 billion, a P/E ratio of 63.30, a price-to-earnings-growth ratio of 1.47 and a beta of 0.86.

Envista (NYSE:NVSTGet Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. The company had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period last year, the company posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts expect that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on NVST. BMO Capital Markets began coverage on shares of Envista in a research note on Wednesday. They issued a “market perform” rating and a $27.00 price objective for the company. Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Morgan Stanley increased their price target on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, April 24th. JPMorgan Chase & Co. raised their price target on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Robert W. Baird boosted their price objective on Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, Envista has a consensus rating of “Hold” and an average target price of $28.54.

View Our Latest Report on NVST

About Envista

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Read More

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.